IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Malcolm R. Starkey, Maximilian W. Plank, Paolo Casolari, Alberto Papi, Stelios Pavlidis, Yike Guo, Guy J.M. Cameron, Tatt Jhong Haw, Anthony Tam, Ma'en Obiedat, Chantal Donovan, Nicole G. Hansbro, Duc H. Nguyen, Prema Mono Nair, Richard Y. Kim, Jay C. Horvat, Gerard E. Kaiko, Scott K. Durum, Peter A. Wark, Don D. Sin, Gaetano Caramori, Ian M. Adcock, Paul S. Foster, Philip M. Hansbro
Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Malcolm R. Starkey, Maximilian W. Plank, Paolo Casolari, Alberto Papi, Stelios Pavlidis, Yike Guo, Guy J.M. Cameron, Tatt Jhong Haw, Anthony Tam, Ma'en Obiedat, Chantal Donovan, Nicole G. Hansbro, Duc H. Nguyen, Prema Mono Nair, Richard Y. Kim, Jay C. Horvat, Gerard E. Kaiko, Scott K. Durum, Peter A. Wark, Don D. Sin, Gaetano Caramori, Ian M. Adcock, Paul S. Foster, Philip M. Hansbro. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: